Aristopharma to add 3 more export destinations in '09
Sunday, 28 December 2008
FE Report
Leading pharmaceuticals manufacturer Aristopharma has set for itself the target of Tk. 3.0 billion in terms of sales for the year 2009 as the local drug manufacturer aims to strengthen its position among the top 10 players of the country.
At the same time, the company would like to add three more export destinations, namely, Malaysia, Lebanon and Nigeria to its current list of nine countries in the upcoming year as it aimed to strengthen its foreign portfolio.
These were revealed at the company's annual sales conference held at the Bangladesh-China Friendship Conference Center in the city Saturday.
Chairman and Managing Director of Aristopharma M A Hassan chaired the event while Director (Marketing and Commercial) Md. Mahboob Hassan, Director (Production) Md. Mahmud Hassan and Director (Finance and Administration) Md. Shahid Hassan and Marketing Manager Noor Hossain also spoke on the occasion.
"Our company does not believe that our responsibility ends only with the manufacturing and marketing of quality medicines. It also extends to the total improvement of the healthcare sector of the country," M A Hassan said.
The annual occasion capped an eventful year for the local drug manufacturer when the company became the first pharmaceutical manufacturer in Bangladesh to conduct bio-equivalence research for its medicine.
At around the same time, the company has introduced its 30 new products to the market while experiencing a growth of more than 20 per cent, which is almost twice as much as the overall growth of this industry in the country, Noor Hossain later told the FE.
Aristopharma at present has a market share of around 5.2 per cent in the local pharmaceuticals market while the company aims to establish itself as one of the top five players by the year 2009.
Starting its journey in 1986; Aristopharma first began to export its products overseas in the year 2000. It is also the first pharmaceutical company in Bangladesh to export its products to Hong Kong as well as the second company to make export to Singapore.
Leading pharmaceuticals manufacturer Aristopharma has set for itself the target of Tk. 3.0 billion in terms of sales for the year 2009 as the local drug manufacturer aims to strengthen its position among the top 10 players of the country.
At the same time, the company would like to add three more export destinations, namely, Malaysia, Lebanon and Nigeria to its current list of nine countries in the upcoming year as it aimed to strengthen its foreign portfolio.
These were revealed at the company's annual sales conference held at the Bangladesh-China Friendship Conference Center in the city Saturday.
Chairman and Managing Director of Aristopharma M A Hassan chaired the event while Director (Marketing and Commercial) Md. Mahboob Hassan, Director (Production) Md. Mahmud Hassan and Director (Finance and Administration) Md. Shahid Hassan and Marketing Manager Noor Hossain also spoke on the occasion.
"Our company does not believe that our responsibility ends only with the manufacturing and marketing of quality medicines. It also extends to the total improvement of the healthcare sector of the country," M A Hassan said.
The annual occasion capped an eventful year for the local drug manufacturer when the company became the first pharmaceutical manufacturer in Bangladesh to conduct bio-equivalence research for its medicine.
At around the same time, the company has introduced its 30 new products to the market while experiencing a growth of more than 20 per cent, which is almost twice as much as the overall growth of this industry in the country, Noor Hossain later told the FE.
Aristopharma at present has a market share of around 5.2 per cent in the local pharmaceuticals market while the company aims to establish itself as one of the top five players by the year 2009.
Starting its journey in 1986; Aristopharma first began to export its products overseas in the year 2000. It is also the first pharmaceutical company in Bangladesh to export its products to Hong Kong as well as the second company to make export to Singapore.